New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Hyperfine, Inc.
HYPR
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

73M

Medical - Devices

Next Earning date - 14 Nov 2024

73M

Medical - Devices

Next Earning date - 14 Nov 2024

1.00USD
Shape-0.01 ( -0.99%)
favorite-chart

Relative Strenght

14
favorite-chart

Volume Buzz

-74%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

52%

Quote Panel

Shape
Updated October 4, 2024
1W -7.41 % 1M 9.79 % 3M 0.00 % 1Y -47.37 %

Key Metrics

Shape
  • Market Cap

    72.62M


  • Shares Outstanding

    72.62M


  • Share in Float

    66.42M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    1


  • Average Volume

    142146


  • Beta

    0.834


  • Range

    0.761-2.1


  • Industry

    Medical - Devices


  • Website

    https://hyperfine.io


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

6.08x

P/S Ratio

1.08x

P/B Ratio

0.0

Debt/Equity

-347.1%

Net Margin

$-0.6

EPS

How HYPR compares to sector?

P/E Ratio

Relative Strength

Shape

HYPR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$19M

Shape425%

2025-Revenue

$0.55

Shape-293%

2025-EPS

$11M

Shape-8%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

downgrade

Previous: Not converted

2024-05-14

Now: Hold

B. Riley

initialise

Previous: Not converted

2022-10-04

Now: Buy

Prescience Point

initialise

Previous: Not converted

2022-10-03

Now: Buy

Wells Fargo

downgrade

Previous: Not converted

2022-08-11

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.19
vs -0.23

Q4.22

arrow
arrow

N/A

-0.19
vs -2.73

Q1.23

arrow
arrow

N/A

-0.17
vs -0.34

Q2.23

arrow
arrow

N/A

-0.15
vs -0.33

Q3.23

arrow
arrow

N/A

-0.15
vs -0.19

Q4.23

arrow
arrow

N/A

-0.15
vs -0.19

Q1.24

arrow
arrow

N/A

-0.14
vs -0.17

Q2.24

arrow
arrow

N/A

-0.14
vs -0.15

Q3.24

arrow
arrow

N/A

-0.14
vs -0.15

Q4.24

arrow
arrow

N/A

-0.15
vs -0.15

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+533%

2.3M  vs 371K

Q4.22

arrow
arrow

+227%

1.4M  vs 436K

Q1.23

arrow
arrow

+75%

2.6M  vs 1.5M

Q2.23

arrow
arrow

+121%

3.4M  vs 1.5M

Q3.23

arrow
arrow

-1%

2.3M  vs 2.3M

Q4.23

arrow
arrow

+89%

2.7M  vs 1.4M

Q1.24

arrow
arrow

+25%

3.3M  vs 2.6M

Q2.24

arrow
arrow

+7%

3.6M  vs 3.4M

Q3.24

arrow
arrow

+41%

3.3M  vs 2.3M

Q4.24

arrow
arrow

+50%

4M  vs 2.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-10%

-0.10
vs -0.15

Q4.22

arrow
arrow

-10%

-0.10
vs -0.10

Q1.23

arrow
arrow

-10%

-0.10
vs -0.10

Q2.23

arrow
arrow

-10%

-0.10
vs -0.10

Q3.23

arrow
arrow

-11%

-0.11
vs -0.10

Q4.23

arrow
arrow

-13%

-0.13
vs -0.11

Q1.24

arrow
arrow

-13%

-0.13
vs -0.13

Q2.24

arrow
arrow

-15%

-0.15
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

37

37
vs 43

-14%

Q4.22

arrow
arrow

38

38
vs 37

3%

Q1.23

arrow
arrow

35

35
vs 38

-8%

Q2.23

arrow
arrow

37

37
vs 35

6%

Q3.23

arrow
arrow

41

41
vs 37

11%

Q4.23

arrow
arrow

51

51
vs 41

24%

Q1.24

arrow
arrow

46

46
vs 51

-10%

Q2.24

arrow
arrow

43

43
vs 46

-7%

Earnings Growth

Latest News